Evidence map›Paper›PMID 35601598›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2022

Brain simulation augments machine-learning-based classification of dementia.

Paul Triebkorn, Leon Stefanovski, Kiret Dhindsa, Margarita-Arimatea Diaz-Cortes, Patrik Bey, Konstantin Bülau, Roopa Pai, Andreas Spiegler, Ana Solodkin, Viktor Jirsa and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Tracking electrophysiological signatures of Alzheimer's disease: a systematic review of multimodal studies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Article
  4. An Interactive Brain Atlas of Knowledge.bioRxiv : the preprint server for biology · 2026
    Article
  5. Excitation-inhibition homeostasis in Alzheimer's disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Altered intrinsic ignition dynamics linked to Amyloid-bioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Paul TriebkornBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Leon StefanovskiBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Kiret DhindsaBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Margarita-Arimatea Diaz-CortesBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Patrik BeyBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Konstantin BülauBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Roopa PaiBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Andreas SpieglerBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Ana SolodkinNeuroscience, Behavioral and Brain Sciences, UT Dallas Richardson Dallas Texas USA.
Viktor JirsaInstitut de Neurosciences des Systèmes Aix Marseille Université Marseille France.
Anthony Randal McIntoshBaycrest Health Sciences Rotman Research Institute Toronto Ontario Canada.
Petra RitterBerlin Institute of Health at Charité - Universitätsmedizin Berlin Berlin Germany.
Alzheimer's Disease Neuroimaging Initiative
Charité - Universitätsmedizin Berlin · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEBaycrest Hospital · CAHumboldt-Universität zu Berlin · DEInstitut de Neurosciences des Systèmes · FRThe University of Texas at Dallas · USUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Computational brain network modeling using The Virtual Brain (TVB) simulation platform acts synergistically with machine learning (ML) and multi-modal neuroimaging to reveal mechanisms and improve diagnostics in Alzheimer's disease (AD). Methods: We enhance large-scale whole-brain simulation in TVB with a cause-and-effect model linking local amyloid beta (Aβ) positron emission tomography (PET) with altered excitability. We use PET and magnetic resonance imaging (MRI) data from 33 participants of the Alzheimer's Disease Neuroimaging Initiative (ADNI3) combined with frequency compositions of TVB-simulated local field potentials (LFP) for ML classification. Results: The combination of empirical neuroimaging features and simulated LFPs significantly outperformed the classification accuracy of empirical data alone by about 10% (weighted F1-score empirical 64.34% vs. combined 74.28%). Informative features showed high biological plausibility regarding the AD-typical spatial distribution. Discussion: The cause-and-effect implementation of local hyperexcitation caused by Aβ can improve the ML-driven classification of AD and demonstrates TVB's ability to decode information in empirical data using connectivity-based brain simulation.

Indexed as

Alzheimer's diseasemachine learningmulti‐scale brain simulationpositron emission tomographyThe Virtual Brain

Identifiers

PMID35601598
PMCPMC9107774
OpenAlexW4285210911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.